Optimizing Anesthesia for Post Partum Tubal Ligations
Status:
Terminated
Trial end date:
2020-12-03
Target enrollment:
Participant gender:
Summary
In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to
low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients
undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded
study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible
for enrollment in this study. Outcomes measured will include: ability to achieve an adequate
level required for surgery (T6), rate of epidural activation, and duration of the block. The
investigators hope to determine the usefulness of each drug using the EVE technique in the
setting of PPBTL.